There were 1,963 press releases posted in the last 24 hours and 438,736 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Akero Therapeutics Announces Positive End-of-Phase 2 Meeting with the FDA and SYNCHRONY Phase 3 Program for Efruxifermin in NASH

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image